You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Completed
  • T Cell Leukemia, Adult
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-26
Jan 26, 2022
U
Recruiting
  • Adult T-cell Leukemia-Lymphoma
  • ATLL
  • Miami, Florida
    University of Miami
2022-01-24
Jan 24, 2022
B
Recruiting
  • T Cell Lymphoma
  • T-cell Leukemia
  • chimeric antigen receptor T cell treatment
  • Beijing, Beijing, China
    Beijing Boren Hospital
2022-02-28
Feb 28, 2022
H
Active, not recruiting
  • T-cell Lymphoma
  • T-cell Leukemia
  • CD4CAR
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
2021-12-02
Dec 2, 2021
W
Recruiting
  • T-Cell Lymphocytic Leukemia
  • +2 more
  • Fludarabine + Cyclophosphamide + CAR7-T Cells
  • Wuhan, Hubei, China
    Union Hospital, Huazhong University of Science and Technology
2022-03-01
Mar 1, 2022
N
Active, not recruiting
  • Adult T-Cell Leukemia (ATL)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-13
Jan 13, 2022
N
Not yet recruiting
  • Adult T-cell Leukemia/Lymphoma
  • +4 more
  • CC-486 (5-azacitidine)
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Completed
  • T-Cell Lymphoma Relapsed
  • +4 more
  • IL-15 plus alemtuzumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2021-07-10
Jul 10, 2021
T
Recruiting
  • Acute T-Lymphocytic Leukemia
  • Venetoclax combined with azacitidine regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
2021-11-25
Nov 25, 2021
B
Recruiting
  • T-cell Leukemia/Lymphoma
  • +2 more
  • chimeric antigen receptor T cell treatment
  • Beijing, Beijing, China
    Beijing Boren Hospital
2021-12-08
Dec 8, 2021
O
Active, not recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
  • Yamagata, Japan
    Yamagata University Hospital
2022-02-21
Feb 21, 2022
N
Active, not recruiting
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2021-11-17
Nov 17, 2021
W
Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
2021-10-28
Oct 28, 2021
U
Recruiting
  • Lymphoma
  • +2 more
  • Brentuximab Vedotin
  • CHEP
  • Hollywood, Florida
  • +3 more
2021-08-12
Aug 12, 2021
D
Recruiting
  • T-cell Lymphoma
  • +5 more
  • Brentuximab vedotin
  • Ann Arbor, Michigan
  • +4 more
2022-02-02
Feb 2, 2022
G
Recruiting
  • CLL
  • +7 more
    • Dresden, Sachsen, Germany
      BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
    2021-12-16
    Dec 16, 2021
    S
    Recruiting
    • Peripheral T Cell Lymphoma
    • +4 more
    • anti-TRBC1 CAR-T cell therapy
    • Shanghai, Shanghai, China
      Xianmin Song
    2021-03-31
    Mar 31, 2021
    J
    Recruiting
    • Recurrent Adult T-Cell Leukemia/Lymphoma
    • +3 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    2021-10-07
    Oct 7, 2021
    B
    Recruiting
    • T Cell Lymphoma
    • T-cell Leukemia
    • Efficacy of LCAR-T2C CAR-T cells
    • Beijing, Beijing, China
    • +1 more
    2021-07-21
    Jul 21, 2021
    F
    Recruiting
    • Prolymphocytic Leukemia
    • T-cell Leukemia
    • Molecular caracterization
    • Le Mans, France
      Chd Le Mans
    2020-08-10
    Aug 10, 2020
    T
    Recruiting
    • CD4+ T Lymphocyte Tumor (T Cell Lymphoma and T Cell Leukemia)
    • Efficacy of LCAR-T2C CAR-T cells
    • Hefei, Anhui, China
    • +2 more
    2021-12-17
    Dec 17, 2021
    K
    Recruiting
    • Non Hodgkin Lymphoma (NHL)
    • +4 more
    • Cincinnati, Ohio
      The Christ Hospital Cancer Center
    2022-02-08
    Feb 8, 2022
    N
    Recruiting
    • Lymphoblastic Leukemia, Acute, Childhood
    • +6 more
    • CAR T-cell therapy
    • Singapore, Singapore
      Allen Yeoh Eng Juh
    2021-09-07
    Sep 7, 2021
    X
    Recruiting
    • T-cell Leukemia
    • T-cell Lymphoma
    • CD7 UCAR-T cells
    • +3 more
    • ChongQing, Chongqing, China
      Department of Hematology, Xinqiao Hospital
    2021-06-21
    Jun 21, 2021
    J
    Not yet recruiting
    • Recurrent T-Cell Large Granular Lymphocyte Leukemia
    • +2 more
    • Oral Azacitidine
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    2021-11-19
    Nov 19, 2021